Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1951.3000 21.20 (1.10%)
NSE Jul 17, 2025 12:02 PM
Volume: 280.7K
 

logo
Lupin Ltd.
14 Jun 2021
1951.30
1.10%
Lupin gets UK nod to launch generic asthma inhaler drug Fostair
Lupin gets UK nod to launch generic asthma inhaler drug Fostair
Moneycontrol
Respiratory diseases affect one in five people. It is the third biggest cause of death in the UK and is a clinical priority for the NHS.
BOB Capital Markets Ltd. released a Buy report for Lupin Ltd. with a price target of 2626.0 on 03 Jul, 2025.
USFDA warning letter to Lupin's US facility
Business Line | 14 Jun 2021 6 more
More from Lupin Ltd.
Recommended
Market trades flat, Kalpataru Projects bags orders worth Rs 2,293 crore in T&D and buildings segments
Trendlyne Marketwatch | 17 Jul 2025, 11:57AM
Five stocks to buy from analysts this week - July 15, 2025
The Baseline | 15 Jul 2025, 06:44PM
Lupin expects normalization by September quarter
| 17 Apr 2020